-
Mashup Score: 5A New Look at P Values for Randomized Clinical Trials - 1 month(s) ago
We have examined the primary efficacy results of 23,551 randomized clinical trials from the Cochrane Database of Systematic Reviews.We estimate that the great majority of trials have much lower sta…
Source: evidence.nejm.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 16Beta-Blockers Post-MI Past Their Expiration Date: REDUCE-AMI - 1 month(s) ago
REDUCE-AMI showed no benefit for routine beta-blockers post–MI in patients with normal ejection fraction. John Mandrola, MD, asks: Does evidence-based medicine need expiration dates?
Source: www.medscape.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 21Unproven healthcare will bankrupt America - 1 month(s) ago
Some doctors and patient advocates are cheering it on
Source: www.sensible-med.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 79Grilling the data: application of specification curve analysis to red meat and all-cause mortality - 1 month(s) ago
To present an application of specification curve analysis—a novel analytic method that involves defining and implementing all plausible and valid analytic approaches for addressing a research question—to nutritional epidemiology.
Source: www.jclinepi.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 79Grilling the data: application of specification curve analysis to red meat and all-cause mortality - 1 month(s) ago
To present an application of specification curve analysis—a novel analytic method that involves defining and implementing all plausible and valid analytic approaches for addressing a research question—to nutritional epidemiology.
Source: www.jclinepi.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 130Preventive Coronary Stents: Not There Yet - 1 month(s) ago
The PREVENT trial on stenting stable plaques deemed vulnerable by imaging criteria suggests a benefit over medical therapy alone. John Mandrola, MD, finds it provocative but not yet ready to act on.
Source: www.medscape.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 79Grilling the data: application of specification curve analysis to red meat and all-cause mortality - 1 month(s) ago
To present an application of specification curve analysis—a novel analytic method that involves defining and implementing all plausible and valid analytic approaches for addressing a research question—to nutritional epidemiology.
Source: www.jclinepi.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 126Preventive Coronary Stents: Not There Yet - 1 month(s) ago
The PREVENT trial on stenting stable plaques deemed vulnerable by imaging criteria suggests a benefit over medical therapy alone. John Mandrola, MD, finds it provocative but not yet ready to act on.
Source: www.medscape.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5We’re Number One—Thanks to You - 1 month(s) ago
You’re one of 630,591 Free Pressers. Help us make you one in a million.
Source: www.thefp.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 181Beta-Blockers Post-MI Past Their Expiration Date: REDUCE-AMI - 1 month(s) ago
REDUCE-AMI showed no benefit for routine beta-blockers post–MI in patients with normal ejection fraction. John Mandrola, MD, asks: Does evidence-based medicine need expiration dates?
Source: www.medscape.comCategories: General Medicine News, Hem/OncsTweet
The reason why the 2/3rds who said yes are correct is found in @ErikVanZwet study on the overestimation of effect in RCTs https://t.co/QJGiSxoDSk Chance of replicating a significant P w an RCT that had a p = 0.04 is about 37% cc @kaulcsmc https://t.co/NUafzlxeUg